Mary Chenevert, MS, CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 7406 Highway 1 Ste 102, Mansura, LA 71350 Phone: 318-240-7680 Fax: 318-240-7681 |
Miss Micaela Rose Dauzat, MS, CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 7408 Highway 1, Mansura, LA 71350 Phone: 318-964-2198 |
Sydney C Welch, M.A., SLP-CFY Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 7406 Highway 1 Ste 102, Mansura, LA 71350 Phone: 318-240-7860 Fax: 318-240-7681 |
Lacey Jeansonne, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 7408 La-1, Mansura, LA 71350 Phone: 318-964-2198 |
Madeline A Bonnette, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 7406 Highway 1 Ste 102, Mansura, LA 71350 Phone: 318-240-7680 |
News Archive
Since 1980, the incidence of ductal carcinoma in situ, or DCIS, one of the most common kinds of early stage breast cancer, has increased more than sevenfold. This sharp increase in DCIS – which is a tumor that contains cancer-like cells but is not considered "true" cancer because the cells have not invaded normal breast tissue – has been accompanied by a flattening in the incidence of true invasive breast cancer.
Candida albicans is one of the leading causes of hospital-acquired infections in immune compromised patients. The risk of both developing candidiasis and the clinical outcome of infection is variable among patients, and the host-dependent factors that contribute to patient susceptibility to C. albicans infection are poorly understood.
Building upon its legacy of technological innovations and innovation awards, FUJIFILM Medical Systems U.S.A., Inc. - the pioneer in digital mammography - will showcase its Aspire product line at the Society of Breast Imaging conference in Los Angeles, CA from April 6-9, 2013.
Researchers have found that a rare but hard-to-treat form of breast cancer is driven by a newly discovered gene. The gene ZNF703 is the first oncogene to be discovered in five years, and it could lead to more effective treatments down the road, Cancer Research UK said.
Brain size matters for intellectual ability and bigger is better, McMaster University researchers have found.
› Verified 1 days ago